UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

The New England journal of medicine, 2014-09, Vol.371 (11), p.993-1004

2014

Volltextzugriff (PDF)

Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients

European heart journal, 2015-08, Vol.36 (30), p.1990-1997

2015

Volltextzugriff (PDF)

Function of Vitamin A in Vertebrate Embryonic Development

The Journal of nutrition, 2001-03, Vol.131 (3), p.705-708

Zile, Maija H.

2001

Volltextzugriff (PDF)

Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure

Journal of the American College of Cardiology, 2016-12, Vol.68 (22), p.2425-2436

2016

Volltextzugriff (PDF)

Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis

Circulation. Heart failure, 2021-03, Vol.14 (3), p.e008052-e008052

2021

Volltextzugriff (PDF)

Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine hearts

Communications biology, 2023-11, Vol.6 (1), p.1203-1203, Article 1203

2023

Volltextzugriff (PDF)

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial

The lancet. Diabetes & endocrinology, 2017-05, Vol.5 (5), p.333-340

2017

Volltextzugriff (PDF)

Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization

Journal of the American College of Cardiology, 2016-07, Vol.68 (3), p.241-248

2016

Volltextzugriff (PDF)

Myocardial infarct expansion and matrix metalloproteinase inhibition

Circulation (New York, N.Y.), 2003-02, Vol.107 (4), p.618-625

2003

Volltextzugriff (PDF)

Comparing LCZ696 With Enalapril According to Baseline Risk Using the MAGGIC and EMPHASIS-HF Risk Scores

Journal of the American College of Cardiology, 2015-11, Vol.66 (19), p.2059-2071

2015

Volltextzugriff (PDF)

Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure

JAMA cardiology, 2020-04, Vol.5 (4), p.432

2020

Volltextzugriff (PDF)

Vitamin A and embryonic development: an overview

The Journal of nutrition, 1998-02, Vol.128 (2S), p.455S-458S

Zile, M.H. (Michigan State University, East Lansing, MI.)

1998

Volltextzugriff (PDF)

Matrix Metalloproteinase Inhibition During the Development of Congestive Heart Failure: Effects on Left Ventricular Dimensions and Function

Circulation research, 1999-08, Vol.85 (4), p.364-376

1999

Volltextzugriff (PDF)

Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency

European heart journal, 2013-03, Vol.34 (9), p.676-683

2013

Volltextzugriff (PDF)

Dynamic Changes in Proteinuria Identify a Form of Cardiorenal Dysfunction Associated with Decreased Survival: An Application of the SOLVD Trial Limited Dataset

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S171-S171

2014

Volltextzugriff (PDF)

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF

Journal of the American College of Cardiology, 2019-02, Vol.73 (7), p.795-806

2019

Volltextzugriff (PDF)

Heart failure with a normal ejection fraction : Is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?

Circulation (New York, N.Y.), 2001-08, Vol.104 (7), p.779-782

2001

Volltextzugriff (PDF)

Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure

JACC. Heart failure, 2018-06, Vol.6 (6), p.489-498

2018

Volltextzugriff (PDF)

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial

European journal of heart failure, 2019-03, Vol.21 (3), p.337-341

2019

Volltextzugriff (PDF)

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

European journal of heart failure, 2013-09, Vol.15 (9), p.1062-1073

2013

Volltextzugriff (PDF)

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women

Journal of the American College of Cardiology, 2019-01, Vol.73 (1), p.29-40

2019

Volltextzugriff (PDF)

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox

European heart journal, 2023-04, Vol.44 (13), p.1136-1153

2023

Volltextzugriff (PDF)

Cytoskeletal mechanics in pressure-overload cardiac hypertrophy

Circulation research, 1997-02, Vol.80 (2), p.281-289

1997

Volltextzugriff (PDF)

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial

European journal of heart failure, 2016-10, Vol.18 (10), p.1228-1234

2016

Volltextzugriff (PDF)

Declining Risk of Sudden Death in Heart Failure

The New England journal of medicine, 2017-07, Vol.377 (1), p.41-51

2017

Volltextzugriff (PDF)

1 – 25 von 740

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(684)
Mit Volltextzugriff
(678)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(459)
Life Sciences & Biomedicine
(440)
Cardiovascular System & Cardiology
(304)
Cardiac & Cardiovascular Systems
(300)
Humans
(286)
Male
(229)
Female
(211)
Heart Failure
(180)
Aged
(163)
Middle Aged
(156)
Animals
(155)
Biological And Medical Sciences
(155)
Heart Failure - Physiopathology
(119)
Medical Sciences
(116)
Heart Failure - Drug Therapy
(97)
Heart
(95)
Peripheral Vascular Disease
(81)
Cardiology. Vascular System
(80)
Stroke Volume
(79)
Cardiovascular
(78)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients

Function of Vitamin A in Vertebrate Embryonic Development

Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure

Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis

Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine hearts

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial

Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization

Myocardial infarct expansion and matrix metalloproteinase inhibition

Comparing LCZ696 With Enalapril According to Baseline Risk Using the MAGGIC and EMPHASIS-HF Risk Scores

Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure

Vitamin A and embryonic development: an overview

Matrix Metalloproteinase Inhibition During the Development of Congestive Heart Failure: Effects on Left Ventricular Dimensions and Function

Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency

Dynamic Changes in Proteinuria Identify a Form of Cardiorenal Dysfunction Associated with Decreased Survival: An Application of the SOLVD Trial Limited Dataset

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF

Heart failure with a normal ejection fraction : Is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?

Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox

Cytoskeletal mechanics in pressure-overload cardiac hypertrophy

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial

Declining Risk of Sudden Death in Heart Failure

Suchergebnisse filtern